Zhang Li-Li, Tang Rui-Jie, Yang Yue-Jin
State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Cardiovasc Med. 2022 Aug 8;9:964034. doi: 10.3389/fcvm.2022.964034. eCollection 2022.
Cardiovascular diseases (CVDs) have been attracting the attention of academic society for decades. Numerous researchers contributed to figuring out the core mechanisms underlying CVDs. Among those, pathological decompensated cellular loss posed by cell death in different kinds, namely necrosis, apoptosis and necroptosis, was widely regarded to accelerate the pathological development of most heart diseases and deteriorate cardiac function. Recently, apart from programmed cell death revealed previously, ferroptosis, a brand-new cellular death identified by its ferrous-iron-dependent manner, has been demonstrated to govern the occurrence and development of different cardiovascular disorders in many types of research as well. Therefore, clarifying the regulatory function of ferroptosis is conducive to finding out strategies for cardio-protection in different conditions and improving the prognosis of CVDs. Here, molecular mechanisms concerned are summarized systematically and categorized to depict the regulatory network of ferroptosis and point out potential therapeutic targets for diverse cardiovascular disorders.
几十年来,心血管疾病(CVDs)一直备受学术界关注。众多研究人员致力于弄清楚心血管疾病的核心机制。其中,由不同类型的细胞死亡,即坏死、凋亡和坏死性凋亡所导致的病理性失代偿性细胞丢失,被广泛认为会加速大多数心脏病的病理发展并使心脏功能恶化。最近,除了先前揭示的程序性细胞死亡外,铁死亡这种以铁离子依赖性方式识别的全新细胞死亡形式,在许多类型的研究中也已被证明与不同心血管疾病的发生和发展有关。因此,阐明铁死亡的调节功能有助于找到不同情况下的心脏保护策略并改善心血管疾病的预后。在此,对相关分子机制进行系统总结和分类,以描绘铁死亡的调节网络并指出针对各种心血管疾病的潜在治疗靶点。